BRIEF published on 04/25/2024 at 18:10, 1 year 10 months ago Valorisation du logiciel MammoRisk® par PREDILIFE Intelligence Artificielle PREDILIFE MammoRisk Évaluation Logiciel Cancer Du Sein
BRIEF published on 04/25/2024 at 18:05, 1 year 10 months ago Valorisation du logiciel MammoRisk® annoncée par PREDILIFE Cancer Du Sein Dépistage Stratifié Valorisation De MammoRisk PRÉDIVIE Médecine Prédictive
BRIEF published on 04/25/2024 at 18:05, 1 year 10 months ago Valuation of MammoRisk® Software Announced by PREDILIFE PREDILIFE Breast Cancer MammoRisk Valuation Stratified Screening Predictive Medicine
PRESS RELEASE published on 04/25/2024 at 18:05, 1 year 10 months ago Valorisation du logiciel MammoRisk(R) Predilife annonce la valorisation du logiciel MammoRisk® par le cabinet SORGEM Evaluation pour potentielles licences industriels. MammoRisk®: solution de dépistage stratifié du cancer du sein. Évaluation entre 191,7 M€ et 223,3 M€ PREDILIFE Cancer Du Sein MammoRisk® Dépistage Stratifié Évaluation
PRESS RELEASE published on 04/25/2024 at 18:00, 1 year 10 months ago Valuation of MammoRisk(R) software PREDILIFE announces valuation of MammoRisk® software by SORGEM Evaluation, determining a value between €191.7 million and €223.3 million. MammoRisk® is a pioneering solution in breast cancer screening targeted at women aged 40 and over Valuation PREDILIFE MammoRisk® Software SORGEM Evaluation Breast Cancer Screening
BRIEF published on 04/24/2024 at 18:35, 1 year 10 months ago PROVISION OF PREDILIFE’S 2023 ANNUAL FINANCIAL REPORT Artificial Intelligence Financial Report 2023 Euronext Growth PREDILIFE
BRIEF published on 04/24/2024 at 18:35, 1 year 10 months ago MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2023 DE PREDILIFE 2023 Euronext Growth Rapport Financier Intelligence Artificielle PREDILIFE
PRESS RELEASE published on 04/24/2024 at 18:30, 1 year 10 months ago MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2023 Predilife rend public son rapport financier annuel 2023, accessible sur son site. La société utilise l'intelligence artificielle pour prédire les risques de pathologies Rapport Financier Investisseurs Intelligence Artificielle PREDILIFE Pathologies
Published on 03/23/2026 at 02:00, 3 hours 11 minutes ago FutureGen Industries Announces Open Market Investments
Published on 03/20/2026 at 13:30, 2 days 15 hours ago Unusual Machines Announces Pricing of Approximately $150 Million Public Offering of Common Stock
Published on 03/23/2026 at 03:35, 1 hour 36 minutes ago Deye 2026 Frankfurt Distributor & Partner Summit Concludes Successfully
Published on 03/22/2026 at 12:23, 16 hours 48 minutes ago Borussia Dortmund and Sebastian Kehl are ending their collaboration with immediate effect
Published on 03/20/2026 at 22:45, 2 days 6 hours ago Investor Alert: Berger Montague (Canada) PC represents investors that purchased shares of Super Micro Computer, Inc. listed on the CBOE Canada and elsewhere
Published on 03/20/2026 at 21:05, 2 days 8 hours ago Fractal EMS Receives ISO/IEC 9001 and 27001 Certifications
Published on 03/20/2026 at 19:00, 2 days 10 hours ago AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 19:00, 2 days 10 hours ago AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 30 avril 2026
Published on 03/20/2026 at 18:15, 2 days 10 hours ago Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 18:15, 2 days 10 hours ago Mise à disposition du Document d’Enregistrement Universel 2025 d’AXA
